# Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation

> **NCT06935890** · PHASE4 · RECRUITING · sponsor: **Murdoch Childrens Research Institute** · enrollment: 100 (estimated)

## Conditions studied

- Allergy
- Immunotherapy
- Venom Allergy

## Interventions

- **OTHER:** Jack Jumper Ant Venom Immunotherapy

## Key facts

- **NCT ID:** NCT06935890
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-25
- **Primary completion:** 2029-10
- **Final completion:** 2029-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06935890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06935890, "Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06935890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*